tiprankstipranks
Savara (DE:YB4P)
NASDAQ:YB4P
Germany Market
YB4P
Savara
RESEARCH TOOLSreports

Savara (YB4P) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

YB4P Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Savara
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

YB4P Stock 12 Month Forecast

Average Price Target

€9.63
▲(96.90% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Savara in the last 3 months. The average price target is €9.63 with a high forecast of €13.80 and a low forecast of €7.76. The average price target represents a 96.90% change from the last price of €4.89.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","7":"€7","14":"€14","3.5":"€3.5","10.5":"€10.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":13.79567232,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€13.80</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.628229639999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€9.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.76006568,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€7.76</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,3.5,7,10.5,14],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.358,5.083974793846154,5.809949587692308,6.535924381538461,7.261899175384615,7.987873969230769,8.713848763076923,9.439823556923077,10.165798350769231,10.891773144615385,11.61774793846154,12.343722732307693,13.069697526153846,{"y":13.79567232,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.358,4.763402279999999,5.16880456,5.5742068399999996,5.979609119999999,6.3850114,6.7904136799999995,7.195815959999999,7.60121824,8.006620519999998,8.412022799999999,8.81742508,9.22282736,{"y":9.628229639999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.358,4.61969736,4.881394719999999,5.14309208,5.40478944,5.6664867999999995,5.92818416,6.18988152,6.45157888,6.71327624,6.9749736,7.23667096,7.49836832,{"y":7.76006568,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.22,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.3,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.68,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.1,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.76,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.398,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.358,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€13.80Average Price Target€9.63Lowest Price Target€7.76
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:YB4P
Andrew Fein
H.C. Wainwright
H.C. Wainwright
€8.62
Buy
76.33%
Upside
Reiterated
06/15/26
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (NASDAQ: KIDS), Gilead Sciences (NASDAQ: GILD) and Savara (NASDAQ: SVRA)
LifeSci Capital Analyst forecast on DE:YB4P
Francois Brisebois
LifeSci Capital
LifeSci Capital
€8.62
Buy
76.33%
Upside
Reiterated
06/09/26
Savara Earns Buy Rating on Strengthened Leadership and High Confidence in MOLBREEVI’s Regulatory Path and Commercial Potential
Oppenheimer Analyst forecast on DE:YB4P
Andreas Argyrides
Oppenheimer
Oppenheimer
€9.48
Buy
93.96%
Upside
Reiterated
06/03/26
Oppenheimer Sticks to Their Buy Rating for Savara (SVRA)
Wells Fargo Analyst forecast on DE:YB4P
Benjamin Burnett
Wells Fargo
Wells Fargo
€7.76
Buy
58.69%
Upside
Assigned
05/22/26
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Intuitive Surgical (ISRG)
Piper Sandler Analyst forecast on DE:YB4P
Yasmeen Rahimi
Piper Sandler
Piper Sandler
€13.8
Buy
182.12%
Upside
Reiterated
05/13/26
Savara (SVRA) Receives a Buy from Piper Sandler
Guggenheim Analyst forecast on DE:YB4P
Vamil Divan
Guggenheim
Guggenheim
€9.48
Buy
93.96%
Upside
Reiterated
05/12/26
Guggenheim Reaffirms Their Buy Rating on Savara (SVRA)
Citizens JMP Analyst forecast on DE:YB4P
Jonathan Wolleben
Citizens JMP
Citizens JMP
€6.9→€9.48
Buy
93.96%
Upside
Reiterated
10/23/25
Savara price target raised to $11 from $8 at Citizens JMPSavara price target raised to $11 from $8 at Citizens JMP
Evercore ISI Analyst forecast on DE:YB4P
Liisa Bayko
Evercore ISI
Evercore ISI
€1.72
Hold
-64.73%
Downside
Reiterated
08/04/25
Evercore ISI Reaffirms Their Hold Rating on Savara (SVRA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on DE:YB4P
Andrew Fein
H.C. Wainwright
H.C. Wainwright
€8.62
Buy
76.33%
Upside
Reiterated
06/15/26
Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (NASDAQ: KIDS), Gilead Sciences (NASDAQ: GILD) and Savara (NASDAQ: SVRA)
LifeSci Capital Analyst forecast on DE:YB4P
Francois Brisebois
LifeSci Capital
LifeSci Capital
€8.62
Buy
76.33%
Upside
Reiterated
06/09/26
Savara Earns Buy Rating on Strengthened Leadership and High Confidence in MOLBREEVI’s Regulatory Path and Commercial Potential
Oppenheimer Analyst forecast on DE:YB4P
Andreas Argyrides
Oppenheimer
Oppenheimer
€9.48
Buy
93.96%
Upside
Reiterated
06/03/26
Oppenheimer Sticks to Their Buy Rating for Savara (SVRA)
Wells Fargo Analyst forecast on DE:YB4P
Benjamin Burnett
Wells Fargo
Wells Fargo
€7.76
Buy
58.69%
Upside
Assigned
05/22/26
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Intuitive Surgical (ISRG)
Piper Sandler Analyst forecast on DE:YB4P
Yasmeen Rahimi
Piper Sandler
Piper Sandler
€13.8
Buy
182.12%
Upside
Reiterated
05/13/26
Savara (SVRA) Receives a Buy from Piper Sandler
Guggenheim Analyst forecast on DE:YB4P
Vamil Divan
Guggenheim
Guggenheim
€9.48
Buy
93.96%
Upside
Reiterated
05/12/26
Guggenheim Reaffirms Their Buy Rating on Savara (SVRA)
Citizens JMP Analyst forecast on DE:YB4P
Jonathan Wolleben
Citizens JMP
Citizens JMP
€6.9→€9.48
Buy
93.96%
Upside
Reiterated
10/23/25
Savara price target raised to $11 from $8 at Citizens JMPSavara price target raised to $11 from $8 at Citizens JMP
Evercore ISI Analyst forecast on DE:YB4P
Liisa Bayko
Evercore ISI
Evercore ISI
€1.72
Hold
-64.73%
Downside
Reiterated
08/04/25
Evercore ISI Reaffirms Their Hold Rating on Savara (SVRA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Savara

3 Months
Francois BriseboisLifeSci Capital
Success Rate
9/16 ratings generated profit
56%
Average Return
+6.11%
Copying Francois Brisebois's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of +6.11% per trade.
1 Year
Jonathan WollebenCitizens JMP
Success Rate
7/15 ratings generated profit
47%
Average Return
+17.01%
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +17.01% per trade.
2 Years
Jonathan WollebenCitizens JMP
Success Rate
14/15 ratings generated profit
93%
Average Return
+44.01%
Copying Jonathan Wolleben's trades and holding each position for 2 Years would result in 93.33% of your transactions generating a profit, with an average return of +44.01% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

YB4P Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
7
12
17
25
20
Buy
1
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
12
17
25
20
In the current month, YB4P has received 20 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. YB4P average Analyst price target in the past 3 months is 9.63.
Each month's total comprises the sum of three months' worth of ratings.

YB4P Financial Forecast

YB4P Earnings Forecast

Next quarter’s earnings estimate for YB4P is -€0.12 with a range of -€0.15 to -€0.11. The previous quarter’s EPS was -€0.13. YB4P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year YB4P has Performed in-line its overall industry.
Next quarter’s earnings estimate for YB4P is -€0.12 with a range of -€0.15 to -€0.11. The previous quarter’s EPS was -€0.13. YB4P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year YB4P has Performed in-line its overall industry.

YB4P Sales Forecast

Next quarter’s sales forecast for YB4P is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. YB4P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year YB4P has Performed in-line its overall industry.
Next quarter’s sales forecast for YB4P is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. YB4P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year YB4P has Performed in-line its overall industry.

YB4P Stock Forecast FAQ

What is DE:YB4P’s average 12-month price target, according to analysts?
Based on analyst ratings, Savara’s 12-month average price target is 9.63.
    What is DE:YB4P’s upside potential, based on the analysts’ average price target?
    Savara has 96.90% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Savara a Buy, Sell or Hold?
          Savara has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Savara’s share price target?
            The average share price target for Savara is 9.63. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €13.80 ,and the lowest forecast is €7.76. The average share price target represents 96.90% Increase from the current price of €4.89.
              What do analysts say about Savara?
              Savara’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Savara?
                To buy shares of DE:YB4P, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.